Less than two years after it overturned Roe v Wade and ended the national right to abortion, the US supreme court is back on the frontlines of the American abortion wars.
On Tuesday, the court heard oral arguments in one of the most highly watched cases of the session, which could dramatically curtail access to mifepristone, a drug typically used in medication abortions. The court is reviewing decisions made by the Food and Drug Administration (FDA) to loosen restrictions on the drug, such as allowing non-physicians to prescribe it, as well as letting providers prescribe it through telehealth rather than in-person appointments.
